Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21362289 | 0.92 | PTGS2 (0.34) | PTGS2NPC1MAPTUSP2LMNA | |
| SCHEMBL21362293 | 0.85 | NPC1 (0.45) | PTGS2NPC1MAPTUSP2LMNA | |
| SCHEMBL21362375 | 0.80 | TSHR (0.40) | PTGS2NPC1MAPTUSP2LMNA | |
| SCHEMBL21362370 | 0.80 | MAPT (0.36) | PTGS2NPC1MAPTUSP2LMNA | |
| SCHEMBL21362323 | 0.79 | MAPT (0.38) | PTGS2NPC1MAPTUSP2LMNA | |
| SCHEMBL21362374 | 0.77 | NPC1 (0.39) | PTGS2NPC1MAPTUSP2LMNA | |
| SCHEMBL21362369 | 0.74 | TSHR (0.39) | PTGS2NPC1MAPTUSP2 | |
| SCHEMBL21362348 | 0.74 | NPC1 (0.31) | NPC1MAPT | |
| SCHEMBL21362292 | 0.67 | NPC1 (0.50) | PTGS2NPC1MAPTUSP2LMNA | |
| SCHEMBL19389196 | 0.66 | CHRNA7 (0.43) | NPC1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190288223-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190288223-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | TPO, RPLP0, RPS10 | PTGS2 4322/4885NPC1 4210/4885MAPT 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.